Lavipharm S.A.

ATSE:LAVI Stock Report

Market Cap: €137.7m

Lavipharm Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.8yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

Lavipharm's (ATH:LAVI) Earnings Aren't As Good As They Appear

Sep 26
Lavipharm's (ATH:LAVI) Earnings Aren't As Good As They Appear

Some Shareholders Feeling Restless Over Lavipharm S.A.'s (ATH:LAVI) P/E Ratio

Aug 06
Some Shareholders Feeling Restless Over Lavipharm S.A.'s (ATH:LAVI) P/E Ratio

Here's Why Lavipharm (ATH:LAVI) Has A Meaningful Debt Burden

Nov 01
Here's Why Lavipharm (ATH:LAVI) Has A Meaningful Debt Burden

We're Not Counting On Lavipharm (ATH:LAVI) To Sustain Its Statutory Profitability

Feb 11
We're Not Counting On Lavipharm (ATH:LAVI) To Sustain Its Statutory Profitability

CEO

Lavipharm has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Vassilis Baloumis
Group CFO & Investor Relations Officer3.1yrsno datano data
Panagiotis Giannouleas
COO & Country Manager5.2yrsno data0.12%
€ 163.5k
Vangelis Paterakis
Chief Accountantno datano datano data
Eleana Nikolopoulou
Group Head of Legal & Compliance and Corporate Secretary2.8yrsno datano data
Ilias Konstantopoulos
Head of Marketing & Sales CHCno datano datano data
Mariza Antonaki
Human Resources Directorno datano datano data
Telemaque Lavidas
Executive Board Memberno datano data0.31%
€ 425.6k
Katerina Tsardaka
Director of Business Development & Acquisitionsless than a yearno datano data
Emmanouil Petrou
Head of Medical Affairs of Lavipharm Hellasno datano datano data
Ioannis Sarigiannidis
Chief Commercial Officer Internationalless than a yearno datano data

2.8yrs

Average Tenure

Experienced Management: LAVI's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Telemaque Lavidas
Executive Board Member5.6yrsno data0.31%
€ 425.6k
Minas Tanes
Chairman of the Board3.7yrsno data0.0013%
€ 1.8k
Venetsiana-Loukia Lavida
Vice President of the Boardno datano data0.076%
€ 104.7k
Christos Diamandopoulos
Non Executive Directorno datano datano data
James Christopoulos
Independent Non Executive Directorno datano datano data
Vicky Kefalas
Independent Non-Executive Board Member2yrsno datano data
Sophia Kounenaki-Efraimoglou
Independent Non Executive Director5.2yrsno datano data

4.4yrs

Average Tenure

Experienced Board: LAVI's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 02:14
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lavipharm S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution